Close
Nordic 9Nordic 9

Longwood Fund (investor - Private Equity)

United States longwoodfund.com
See something wrong or missing? Let us know
Offices:Boston

Longwood Fund is an American investment firm that finances science-based companies that develop novel solutions for medical problems.

 

Average round investment:62.26M USD
Average number per year:1.3
Distribution: 2023 (2)2022 (1)2021 (1)
Portfolio companies: United Kingdom Sitryx TherapeuticsItaly AAVantgarde BioUnited Kingdom Pulmocide
Mostly invests in: United Kingdom United Kingdom (3) Health services (4)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Longwood Fund mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Longwood Fund

Name Criteria
Canada CTI Life Sciences
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Singapore ABC World
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Bristol-Myers Squibb
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Northpond Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Samsara BioCapital
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Switzerland HBM Healthcare Investments
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States What If Ventures
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Kairos
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Arch Venture Partners
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States Research Corporation Technologies
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Top